LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - ARS Pharmaceuticals (NASDAQ: SPRY)

Follow NASDAQ:SPRY Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
11/12/2024
Sell
$16.76
45,045
$755K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
11/12/2024
Sell
$17.64
4,955
$87K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
11/12/2024
Sell
$16.76
45,124
$756K
1.25M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
11/12/2024
Sell
$17.64
4,876
$86K
1.25M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
11/12/2024
Sell
$16.76
45,045
$755K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
11/12/2024
Sell
$17.64
4,955
$87K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
11/12/2024
Sell
$16.76
45,124
$756K
1.25M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
11/12/2024
Sell
$17.64
4,876
$86K
1.25M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/11/2024
Sell
$17.45
40,596
$708K
5.50M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/11/2024
Sell
$17.45
40,596
$708K
5.50M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/11/2024
Sell
$18.15
223,632
$4.059M
5.27M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/11/2024
Sell
$18.15
223,632
$4.059M
5.27M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/12/2024
Sell
$17.16
7,853
$135K
5.27M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/12/2024
Sell
$17.16
7,854
$135K
5.27M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/12/2024
Sell
$17.77
9,554
$170K
5.26M
NASDAQ SPRY ARS Pharmaceuticals
Flynn James E / 10 percent owner
11/12/2024
Sell
$17.77
9,553
$170K
5.26M
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
10/16/2024
Sell
$1.50
12,500
$19K
802,330
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
10/16/2024
Buy
$1.50
12,500
$19K
17,449
NASDAQ SPRY ARS Pharmaceuticals
Scott Kathleen D. / officer: Chief Financial Officer
10/16/2024
Sell
$16.00
12,500
$200K
4,949
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
10/15/2024
Sell
$14.86
48,550
$722K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
10/15/2024
Sell
$15.25
1,450
$22K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
10/15/2024
Sell
$14.88
50,000
$744K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
10/15/2024
Sell
$14.86
48,550
$722K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
10/15/2024
Sell
$15.25
1,450
$22K
1.40M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
10/15/2024
Sell
$14.88
50,000
$744K
1.30M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
10/08/2024
Sell
$13.83
50,000
$691K
1.35M
NASDAQ SPRY ARS Pharmaceuticals
Tanimoto Sarina / 10 percent owner, officer: CHIEF MEDICAL OFFICER
10/08/2024
Sell
$13.83
50,000
$691K
1.35M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
10/08/2024
Sell
$13.83
50,000
$691K
1.35M
NASDAQ SPRY ARS Pharmaceuticals
Lowenthal Richard E / director, 10 percent owner, officer: PRESIDENT AND CEO
10/08/2024
Sell
$13.83
50,000
$691K
1.35M
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
09/18/2024
Sell
$1.50
10,000
$15K
594,588
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
09/18/2024
Buy
$1.50
10,000
$15K
15,693
NASDAQ SPRY ARS Pharmaceuticals
Karas Eric / officer: Chief Commercial Officer
09/18/2024
Sell
$14.00
10,000
$140K
5,693

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous